New imaging study aims to speed up myotonic dystrophy trials

NCT ID NCT07362875

First seen Jan 31, 2026 · Last updated May 24, 2026 · Updated 15 times

Summary

This study is not testing a treatment. Instead, it aims to develop a better way to measure muscle changes in people with myotonic dystrophy using MRI scans. Researchers will enroll 75 adults (ages 18-65) with or without the condition to see if muscle imaging can serve as a reliable biomarker for future clinical trials. The goal is to help speed up the search for effective treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wake Forest University Health Sciences

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.